Table A6.

Exemestane Plus Triptorelin: Patients With Treatment Nonadherence (n = 10) and Sampling Time From Last Triptorelin Injection

Patient ID	Visit Time Point, Months	Blood Draw, Months	Blood Sample Since Last Injection, Days	E2 (pg/mL)	Duration of Exemestane, Months	Duration of Triptorelin, Months
A1	3	3	6	41.9	4.4	12
	6	6			4.4	12
	9				4.4	12
	12	12*	28	3.55*	4.4	12
A2	3	3	28	0.625	4.2	12
	6	6			4.2	12
	9				4.2	12
	12				4.2	12
A3	3	3	28	32.1	8.5	9.2
	6	6	28	0.625	8.5	9.2
	9	9	7	0.625	8.5	9.2
A4	3	3			11.8	12
	6	6	4	1.03	11.8	12
	9				11.8	12
	12	12	16	0.715	11.8	12
A5	3	3	38	0.625	9	12
	6	6	25	0.625	9	12
	9				9	12
A6	3	3*	23	2.33*	1.2	12
	6	6*	19	2.47*	1.2	12
	9				1.2	12
	12	12*	28	3.57*	1.2	12
A7	3	3		7.48	0.3	4.3
	6	6			0.3	4.3
	12	12		7.38	0.3	4.3
A8	3	3	31	0.625	7.8	12
	6	6	29	0.625	7.8	12
	9				7.8	12
	12				7.8	12
A9	3	3	6	0.625	3.5	3.7
	6				3.5	3.7
A10	3	3	21	3.95	12	12
	6	6	14	1.6	12	12
	9				12	12
	12	12	28	0.625	12	12

Abbreviations: E2, estradiol.

^*The patient was on tamoxifen at this blood draw.